Commentary
President-elect Donald Trump
Regulatory & QualityAdvaMed Reacts to Second Trump TermAdvaMed Reacts to Second Trump Term
Trump’s in. Here’s how one medtech association is reacting to the news, and how it intends to work with the president-elect.
Sign up for the QMED & MD+DI Daily newsletter.